Global Skin Disease Morbidity and Mortality: An Update From the Global Burden of Disease Study 2013

Chante Karimkhani, Robert P Dellavalle, Luc E Coffeng, Carsten Flohr, Roderick J Hay, Sinéad M Langan, Elaine O Nsoesie, Alize J Ferrari, Holly E Erskine, Jonathan I Silverberg, Theo Vos, Mohsen Naghavi, Chante Karimkhani, Robert P Dellavalle, Luc E Coffeng, Carsten Flohr, Roderick J Hay, Sinéad M Langan, Elaine O Nsoesie, Alize J Ferrari, Holly E Erskine, Jonathan I Silverberg, Theo Vos, Mohsen Naghavi

Abstract

Importance: Disability secondary to skin conditions is substantial worldwide. The Global Burden of Disease Study 2013 includes estimates of global morbidity and mortality due to skin diseases.

Objective: To measure the burden of skin diseases worldwide.

Data sources: For nonfatal estimates, data were found by literature search using PubMed and Google Scholar in English and Spanish for years 1980 through 2013 and by accessing administrative data on hospital inpatient and outpatient episodes. Data for fatal estimates were based on vital registration and verbal autopsy data.

Study selection: Skin disease data were extracted from more than 4000 sources including systematic reviews, surveys, population-based disease registries, hospital inpatient data, outpatient data, cohort studies, and autopsy data. Data metrics included incidence, prevalence, remission, duration, severity, deaths, and mortality risk.

Data extraction and synthesis: Data were extracted by age, time period, case definitions, and other study characteristics. Data points were modeled with Bayesian meta-regression to generate estimates of morbidity and mortality metrics for skin diseases. All estimates were made with 95% uncertainty intervals.

Main outcomes and measures: Disability-adjusted life years (DALYs), years lived with disability, and years of life lost from 15 skin conditions in 188 countries.

Results: Skin conditions contributed 1.79% to the global burden of disease measured in DALYs from 306 diseases and injuries in 2013. Individual skin diseases varied in size from 0.38% of total burden for dermatitis (atopic, contact, and seborrheic dermatitis), 0.29% for acne vulgaris, 0.19% for psoriasis, 0.19% for urticaria, 0.16% for viral skin diseases, 0.15% for fungal skin diseases, 0.07% for scabies, 0.06% for malignant skin melanoma, 0.05% for pyoderma, 0.04% for cellulitis, 0.03% for keratinocyte carcinoma, 0.03% for decubitus ulcer, and 0.01% for alopecia areata. All other skin and subcutaneous diseases composed 0.12% of total DALYs.

Conclusions and relevance: Skin and subcutaneous diseases were the 18th leading cause of global DALYs in Global Burden of Disease 2013. Excluding mortality, skin diseases were the fourth leading cause of disability worldwide.

Conflict of interest statement

Conflict of Interest Disclosures: Drs Coffeng, Nsoesie, Ferrari, Erskine, Vos, and Naghavi are or have been employed by the Institute for Health Metrics and Evaluation during the time of study. Drs Karimkhani, Dellavalle, Hay, Langan, and Silverberg are GBD collaborators without funding. Dr Dellavalle is an employee of the US Department of Veterans Affairs. Dr Langan is supported by a National Institute for Health Research Clinician Scientist award from the United Kingdom Department of Health. Drs Ferrari and Erskine are affiliated with the Queensland Centre for Mental Health research, which receives funding from the Queensland Department of Health. No other disclosures are reported.

Figures

Figure 1.. Age Distribution of Skin and…
Figure 1.. Age Distribution of Skin and Subcutaneous Disease Burden
This figure shows disability-adjusted life year (DALY) rate per 100 000 persons from 15 skin disease categories throughout the human life span.
Figure 2.. Regional Distribution of Skin and…
Figure 2.. Regional Distribution of Skin and Subcutaneous Disease Burden
This figure shows disability-adjusted life year (DALY) rate per 100 000 persons from 15 skin disease categories throughout 21 world regions.

References

    1. Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369(5):448-457.
    1. Murray CJ, Ezzati M, Flaxman AD, et al. . GBD 2010: design, definitions, and metrics. Lancet. 2012;380(9859):2063-2066.
    1. Murray CJ, Vos T, Lozano R, et al. . Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2013;381(9867):628]. Lancet. 2012;380(9859):2197-2223.
    1. Institute for Health Metrics and Evaluation . The Global Burden of Disease: Generating Evidence, Guiding Policy. Seattle, WA: Institute for Health Metrics and Evaluation; 2013.
    1. Hay RJ, Johns NE, Williams HC, et al. . The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134(6):1527-1534.
    1. Global Burden of Disease Study 2013 Collaborators . Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.
    1. Neal RD, Cannings-John R, Hood K, et al. . Excision of malignant melanomas in North Wales: effect of location and surgeon on time to diagnosis and quality of excision. Fam Pract. 2008;25(4):221-227.
    1. Nolan RC, Chan MT, Heenan PJ. A clinicopathologic review of lethal nonmelanoma skin cancers in Western Australia. J Am Acad Dermatol. 2005;52(1):101-108.
    1. National Cancer Institute . SEER cancer statistics review 1975-2013. . Accessed May 16, 2016.
    1. Salomon JA, Haagsma JA, Davis A, et al. . Disability weights for the global burden of disease 2013 study. Lancet Glob Health. 2015;3(11):e712-e723.
    1. GBD 2013 Mortality and Causes of Death Collaborators . Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117-171.
    1. United Nations . World population prospects: 2015 revision. . Accessed February 17, 2016.
    1. GBD Compare. . Accessed April 1, 2016.
    1. Global Burden of Disease Study 2013 Collaborators . Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.
    1. Murray CJ, Barber RM, Foreman KJ, et al. ; GBD 2013 DALYs and HALE Collaborators . Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet. 2015;386(10009):2145-2191.
    1. Institute for Health Metrics and Evaluation (IHME) . Financing Global Health 2015: Development Assistance Steady on the Path to New Global Goals. Seattle, WA: IHME; 2016.
    1. International Federation of Dermatology Clinical Trials Networks . About the Federation. . Accessed January 26, 2017.
    1. Robson KJ, Piette WW. Cutaneous manifestations of systemic diseases. Med Clin North Am. 1998;82(6):1359-1379.
    1. Hay RJ, Augustin M, Griffiths CE, Sterry W; Board of the International League of Dermatological Societies and the Grand Challenges Consultation groups . The global challenge for skin health. Br J Dermatol. 2015;172(6):1469-1472.
    1. Freeman EE. A seat at the big table: expanding the role of dermatology at the World Health Organization and beyond. J Invest Dermatol. 2014;134(11):2663-2665.
    1. The International Foundation for Dermatology . Our aim. . Accessed August 31, 2016.
    1. UNAIDS . The Gap Report. . Accessed August 30, 2016.
    1. Lekalakala PT, Khammissa RA, Kramer B, Ayo-Yusuf OA, Lemmer J, Feller L. Oculocutaneous albinism and squamous cell carcinoma of the skin of the head and neck in sub-Saharan Africa. J Skin Cancer. 2015;2015:167847.
    1. International Foundation for Dermatology . Progress report 2015-16. . Accessed September 2, 2016.
    1. The Cochrane Collaboration . About us. . Accessed August 30, 2016.
    1. Cochrane Skin . Prioritisation of dermatological research. . Accessed August 30, 2016.
    1. Karimkhani C, Boyers LN, Prescott L, et al. . Global burden of skin disease as reflected in Cochrane Database of Systematic Reviews. JAMA Dermatol. 2014;150(9):945-951.
    1. Shiffman J. Knowledge, moral claims and the exercise of power in global health. Int J Health Policy Manag. 2014;3(6):297-299.
    1. Rudan I, Chan KY. Global health metrics needs collaboration and competition. Lancet. 2015;385(9963):92-94.

Source: PubMed

3
구독하다